Abstract:AIM To study the influence of different doses of tacrolimus (FK506) on gut microbiota after liver transplantation (LT) in rats. METHODS Specific pathogen-free Brown Norway (BN) rats and Lewis rats were separated into five groups: (1) Tolerance group (BN-BN LT, n = 8); (2) rejection group (Lewis-BN LT, n = 8); (3) high dosage FK506 (FK506-H) group (Lewis-BN LT, n = 8); (4) middle dosage FK506 (FK506-M) group (Lewis-BN LT, n = 8); and (5) low dosage FK506 (FK506-L) group (Lewis-BN LT, n = 8). FK506 was administered to recipients at a dose of 1.0 mg/kg, 0.5 mg/kg, and 0.1 mg/kg body weight for 29 d after LT to the FK506-H, FK506-M, and FK506-L groups, respectively. On the 30th day after LT, all rats were sampled and euthanized. Blood samples were harvested for liver function and plasma endotoxin testing. Hepatic graft and ileocecal tissues were collected for histopathology observation. Ileocecal contents were used for DNA extraction, Real-time quantitative polymerase chain reaction (RT-PCR) and digital processing of denaturing gradient gel electrophoresis (DGGE) profiles and analysis. RESULTS Compared to the FK506-H and FK506-L groups, FK506-M was optimal for maintaining immunosuppression and inducing normal graft function; the FK506-M maintained gut barrier integrity and low plasma endotoxin levels; furthermore, DGGE results showed that FK506-M induced stable gut microbiota. Diversity analysis indicated that FK506-M increased species richness and rare species abundance, and cluster analysis confirmed the stable gut microbiota induced by FK506-M. Phylogenetic tree analysis identified crucial bacteria associated with FK506-M; seven of the nine bacteria that were decreased corresponded to Bacteroidetes, while increased bacteria were of the Bifidobacterium species. FK506-M increased Faecalibacterium prausnitzii and Bifidobacterium spp. and decreased Bacteroides-Prevotella and Enterobacteriaceae, as assessed by RT-PCR, which confirmed the crucial bacterial alterations identified through DGGE. CONCLUSION Compared to the low or high dosage of FK506, an optimal dosage of FK506 induced immunosuppression, normal graft function and stable gut microbiota following LT in rats. The stable gut microbiota presented increased probiotics and decreased potential pathogenic endotoxin-producing bacteria. These findings provide a novel strategy based on gut microbiota for immunosuppressive dosage assessment for recipients following LT.

Comparative nutrition, growth and longevity

Distribution and Drug Resistance of Infection Pathogens in Patients of Post-Op of Liver Transplantation

Assessment of Microbiome Variation During the Perioperative Period in Liver Transplant Patients: a Retrospective Analysis.

The Gut Microbiota in Liver Transplantation Recipients During the Perioperative Period

Role of the Immune System in Liver Transplantation and Its Implications for Therapeutic Interventions

Extrahepatic organs in the development of non-alcoholic fatty liver disease in liver transplant patients

Effect of Intestinal Microbiota Alteration on Hepatic Damage in Rats with Acute Rejection After Liver Transplantation

Structural Shifts of Fecal Microbial Communities in Rats with Acute Rejection after Liver Transplantation

Unraveling Intestinal Microbial Shifts in ESRD and Kidney Transplantation: Implications for Disease-Related Dysbiosis

Intestinal Microbiota and Innate Immunity-Related Gene Alteration in Cirrhotic Rats with Liver Transplantation

Changes of Gut Bacteria and Immune Parameters in Liver Transplant Recipients

Optimal immunosuppressor induces stable gut microbiota after liver transplantation.

Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality.

Intestinal microbiota links to allograft stability after lung transplantation: a prospective cohort study

Variation in the Gut Microbial Community is Associated with the Progression of Liver Regeneration

Fecal metabolite profiling identifies liver transplant recipients at risk for postoperative infection

Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors

Bacterial Infections After Liver Transplantation and the Role of Oral Selective Digestive Decontamination: A Retrospective Cohort Study

Bacteriological, Drug-Resistant and Correlative Analysis of Infection after Liver Transplantation

Gut microbiota and allogeneic transplantation

Efficacy of Probiotics Supplementation on the Prognosis of Patients After Liver Transplantation: a Systematic Review and Meta-analysis